CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 133 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $198,000 | -2.5% | 42,850 | -18.6% | 0.00% | -25.0% |
| Q1 2020 | $203,000 | -20.1% | 52,659 | -22.2% | 0.00% | 0.0% |
| Q4 2019 | $254,000 | -5.2% | 67,659 | +34.2% | 0.00% | 0.0% |
| Q3 2019 | $268,000 | +857.1% | 50,409 | +105.8% | 0.00% | +300.0% |
| Q4 2016 | $28,000 | – | 24,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 213,609 | $1,446,000 | 2.75% |
| GABLES CAPITAL MANAGEMENT INC. | 449,164 | $3,041,000 | 1.81% |
| Prairiewood Capital, LLC | 261,403 | $1,770,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 9,572,000 | $64,802,000 | 1.06% |
| Quantedge Capital Pte Ltd | 360,100 | $2,438,000 | 1.03% |
| SummerHaven Investment Management, LLC | 151,384 | $1,025,000 | 0.55% |
| GLOBEFLEX CAPITAL L P | 609,030 | $4,124,000 | 0.42% |
| EAM Global Investors LLC | 347,899 | $2,355,000 | 0.42% |
| Lanham O'Dell & Company, Inc. | 50,000 | $339,000 | 0.27% |
| EAM Investors, LLC | 239,071 | $1,619,000 | 0.27% |